NASDAQ:AHCO AdaptHealth (AHCO) Stock Forecast, Price & News $10.30 -0.11 (-1.06%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$10.21▼$10.4650-Day Range$10.00▼$12.5252-Week Range$9.91▼$27.48Volume994,223 shsAverage Volume1.20 million shsMarket Capitalization$1.38 billionP/E Ratio85.83Dividend YieldN/APrice Target$18.92 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media AdaptHealth MarketRank™ ForecastAnalyst RatingModerate Buy2.57 Rating ScoreUpside/Downside83.7% Upside$18.92 Price TargetShort InterestHealthy15.81% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.52Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth20.59%From $0.68 to $0.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.10 out of 5 starsMedical Sector11th out of 986 stocksHome Health Care Services Industry1st out of 8 stocks 3.3 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.92, AdaptHealth has a forecasted upside of 83.7% from its current price of $10.30.Amount of Analyst CoverageAdaptHealth has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted15.81% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 7.7.Change versus previous monthShort interest in AdaptHealth has recently decreased by 8.92%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 2.5 News and Social Media Coverage News SentimentAdaptHealth has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for AdaptHealth this week, compared to 4 articles on an average week.Search Interest8 people have searched for AHCO on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.MarketBeat Follows5 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have not sold or bought any company stock.Percentage Held by Insiders17.30% of the stock of AdaptHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions86.33% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 5.0 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 20.59% in the coming year, from $0.68 to $0.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is 85.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.97.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is 85.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.28.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.62. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AdaptHealth (NASDAQ:AHCO) StockAdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.Read More Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address AHCO Stock News HeadlinesJune 9, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Shares Up 6.1%June 7, 2023 | markets.businessinsider.comAdaptHealth (AHCO) was upgraded to a Hold Rating at Stifel NicolausJune 9, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 31, 2023 | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) Sees Large Decline in Short InterestMay 25, 2023 | wsj.comAdaptHealth Corp.May 20, 2023 | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of "Moderate Buy" from AnalystsMay 17, 2023 | markets.businessinsider.comStifel Nicolaus upgrades AdaptHealth (AHCO) to a HoldMay 15, 2023 | finance.yahoo.comAdaptHealth to Participate in RBC Global Healthcare ConferenceJune 9, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 13, 2023 | americanbankingnews.comSVB Leerink Research Analysts Decrease Earnings Estimates for AdaptHealth Corp. (NASDAQ:AHCO)May 13, 2023 | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) to Post Q2 2023 Earnings of $0.13 Per Share, SVB Leerink ForecastsMay 13, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Trading Down 6.8% Following Analyst DowngradeMay 12, 2023 | msn.comB of A Securities Downgrades AdaptHealth (AHCO)May 12, 2023 | msn.comRBC Capital Maintains AdaptHealth (AHCO) Outperform RecommendationMay 12, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Price Target Cut to $18.00 by Analysts at Royal Bank of CanadaMay 12, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Downgraded by Bank of AmericaMay 12, 2023 | msn.comStifel Downgrades AdaptHealth (AHCO)May 11, 2023 | msn.comAdaptHealth CEO Stephen Griggs to step downMay 11, 2023 | finance.yahoo.comAdaptHealth Corp. Partners With Humana on Value-Based CareMay 11, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Reaches New 12-Month Low at $10.21May 11, 2023 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Price Target Lowered to $20.00 at Robert W. BairdMay 11, 2023 | americanbankingnews.comStifel Nicolaus Downgrades AdaptHealth (NASDAQ:AHCO) to HoldMay 10, 2023 | msn.comAdaptHealth Q1 2023 Earnings PreviewMay 10, 2023 | msn.comBaird Maintains AdaptHealth (AHCO) Outperform RecommendationMay 10, 2023 | bizjournals.comAdaptHealth CEO Stephen Griggs to step down 'by mutual agreement'May 10, 2023 | msn.comWhy AdaptHealth Stock Got Slammed TodayMay 10, 2023 | msn.comUnusual Put Option Trade in AdaptHealth (AHCO) Worth $107.18KSee More Headlines AHCO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AHCO Company Calendar Last Earnings11/04/2021Today6/09/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,900Year FoundedN/APrice Target and Rating Average Stock Price Forecast$18.92 High Stock Price Forecast$30.00 Low Stock Price Forecast$11.00 Forecasted Upside/Downside+82.5%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$0.12 Trailing P/E Ratio86.42 Forward P/E Ratio15.25 P/E Growth0.62Net Income$69.32 million Net Margins1.44% Pretax Margin2.16% Return on Equity3.17% Return on Assets1.31% Debt Debt-to-Equity Ratio1.00 Current Ratio1.23 Quick Ratio0.97 Sales & Book Value Annual Sales$3.00 billion Price / Sales0.46 Cash Flow$2.99 per share Price / Cash Flow3.47 Book Value$16.01 per share Price / Book0.65Miscellaneous Outstanding Shares134,172,000Free Float110,960,000Market Cap$1.39 billion OptionableNot Optionable Beta0.64 Key ExecutivesStephen P. GriggsChief Executive Officer & DirectorJoshua ParnesPresident & DirectorShaw RietkerkChief Operating OfficerJason A. ClemensChief Financial OfficerAlbert A. PrastChief Technology OfficerKey CompetitorsAddus HomeCareNASDAQ:ADUSEnhabitNYSE:EHABAmedisysNASDAQ:AMEDBiomea FusionNASDAQ:BMEAReplimune GroupNASDAQ:REPLView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Sold 83,837 shares on 5/22/2023Ownership: 0.977%JPMorgan Chase & Co.Sold 166,886 shares on 5/18/2023Ownership: 0.816%New York State Common Retirement FundBought 46,499 shares on 5/18/2023Ownership: 0.304%Thrivent Financial for LutheransSold 2,668 shares on 5/17/2023Ownership: 0.056%Squarepoint Ops LLCBought 2,731 shares on 5/16/2023Ownership: 0.011%View All Insider TransactionsView All Institutional Transactions AHCO Stock - Frequently Asked Questions Should I buy or sell AdaptHealth stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AHCO shares. View AHCO analyst ratings or view top-rated stocks. What is AdaptHealth's stock price forecast for 2023? 7 Wall Street research analysts have issued twelve-month price targets for AdaptHealth's shares. Their AHCO share price forecasts range from $11.00 to $30.00. On average, they anticipate the company's share price to reach $18.92 in the next year. This suggests a possible upside of 82.5% from the stock's current price. View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts. How have AHCO shares performed in 2023? AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO stock has decreased by 46.0% and is now trading at $10.37. View the best growth stocks for 2023 here. Are investors shorting AdaptHealth? AdaptHealth saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 11,640,000 shares, a decrease of 8.9% from the April 30th total of 12,780,000 shares. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is presently 7.7 days. Approximately 15.8% of the shares of the stock are sold short. View AdaptHealth's Short Interest. When is AdaptHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our AHCO earnings forecast. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) posted its quarterly earnings data on Thursday, November, 4th. The company reported $0.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.28 by $0.08. The company earned $653.30 million during the quarter, compared to analyst estimates of $638.74 million. AdaptHealth had a net margin of 1.44% and a trailing twelve-month return on equity of 3.17%. The company's quarterly revenue was up 129.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.05 EPS. What ETFs hold AdaptHealth's stock? ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Fidelity Small-Mid Cap Opportunities ETF (FSMO), Invesco S&P SmallCap Value with Momentum ETF (XSVM) and First Trust Small Cap Growth AlphaDEX Fund (FYC). What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS). What is AdaptHealth's stock symbol? AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO." Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.81%), FMR LLC (7.27%), Truist Financial Corp (2.90%), Rubric Capital Management LP (2.46%), Sumitomo Mitsui Trust Holdings Inc. (2.44%) and State Street Corp (1.97%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AdaptHealth's stock price today? One share of AHCO stock can currently be purchased for approximately $10.37. How much money does AdaptHealth make? AdaptHealth (NASDAQ:AHCO) has a market capitalization of $1.39 billion and generates $3.00 billion in revenue each year. The company earns $69.32 million in net income (profit) each year or $0.12 on an earnings per share basis. How many employees does AdaptHealth have? The company employs 10,900 workers across the globe. How can I contact AdaptHealth? AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com. This page (NASDAQ:AHCO) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.